Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy: a case report.
Baykal
C
C
Department of Obstetrics and Gynecology, Hacettepe University, School of Medicine, Ankara, Turkey.
Zengin
N
N
Coşkun
F
F
Güler
N
N
Ayhan
A
A
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage* / Q000009:adverse effects; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011256:Pregnancy Outcome
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D006918:Hydroxyurea